The Addition of Rituximab to Cyclophosphamide, Doxorubicine, Vincristine and Prednisone (CHOP) Prolongs Overall Survival in Previously Untreated Mantle Cell Lymphoma: A Long Term Pooled Trials Analysis
暂无分享,去创建一个
W. Klapper | E. Hoster | W. Hiddemann | A. Hüttmann | M. Dreyling | J. Krauter | B. Metzner | M. Unterhalt | C. Schmidt | B. Glass | J. Duell | K. Hübel | K. Schaefer-Eckart | Linmiao Jiang | J. Bittenbring | Luca Fischer